Esperion Therapeutics ESPR Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's interest paid?
- Esperion Therapeutics (ESPR) reported interest paid of $4.07M in Q4 2025.
- How has Esperion Therapeutics's interest paid changed year-over-year?
- Esperion Therapeutics's interest paid increased by 43.4% year-over-year, from $2.84M to $4.07M.
- What is the long-term trend for Esperion Therapeutics's interest paid?
- Over 2 years (2023 to 2025), Esperion Therapeutics's interest paid has grown at a 23.9% compound annual growth rate (CAGR), from $10.6M to $16.27M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.